Other Species / Isoforms
  BUB1B (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S12
KKEGGALSEAMsLEG
0 1
BUB1B (human) KKEGGALSEAMsLEG S12
BUB1B iso2 (human) KKEGGALSEAMSLEG S12
BUB1B iso3 (human) KKEGGALSEAMSLEG S12
BUB1B (mouse) ___MAEAsEAMCLEG S5-p
BUB1B (rat) ___MAAASEATCVEG S5
S16-p
GALSEAMsLEGDEWE
0 2
BUB1B (human) GALSEAMsLEGDEWE S16-p
BUB1B iso2 (human) GALSEAMSLEGDEWE S16
BUB1B iso3 (human) GALSEAMSLEGDEWE S16
BUB1B (mouse) AEAsEAMCLEGAEWE C9
BUB1B (rat) AAASEATCVEGDEWE C9
K26-ub
GDEWELSkENVQPLR
0 1
BUB1B (human) GDEWELSkENVQPLR K26-ub
BUB1B iso2 (human) GDEWELSKENVQPLR K26
BUB1B iso3 (human) GDEWELSKENVQPLR K26
BUB1B (mouse) GAEWELSKENIQPLR K19
BUB1B (rat) GDEWELSKENVQPLR K19
S39-p
LRQGRIMstLQGALA
0 6
BUB1B (human) LRQGRIMstLQGALA S39-p
BUB1B iso2 (human) LRQGRIMSTLQGALA S39
BUB1B iso3 (human) LRQGRIMSTLQGALA S39
BUB1B (mouse) LRHGRVMSTLQGALA S32
BUB1B (rat) LRHGRIMATLQGALA A32
T40-p
RQGRIMstLQGALAQ
0 1
BUB1B (human) RQGRIMstLQGALAQ T40-p
BUB1B iso2 (human) RQGRIMSTLQGALAQ T40
BUB1B iso3 (human) RQGRIMSTLQGALAQ T40
BUB1B (mouse) RHGRVMSTLQGALAK T33
BUB1B (rat) RHGRIMATLQGALAQ T33
T54-p
QESACNNtLQQQkRA
Upstream
1 1
Treatment
  • AZ3146
  • BI2536
  • SP600125
  • ZM447439
BUB1B (human) QESACNNtLQQQkRA T54-p
BUB1B iso2 (human) QESACNNTLQQQKRA T54
BUB1B iso3 (human) QESACNNTLQQQKRA T54
BUB1B (mouse) QESAGHTALQQQKRA A48
BUB1B (rat) QESACSTTLQQQKWA T48
K59-ub
NNtLQQQkRAFEyEI
0 1
BUB1B (human) NNtLQQQkRAFEyEI K59-ub
BUB1B iso2 (human) NNTLQQQKRAFEYEI K59
BUB1B iso3 (human) NNTLQQQKRAFEYEI K59
BUB1B (mouse) HTALQQQKRAFESEI K53
BUB1B (rat) STTLQQQKWAFESEI K53
Y64-p
QQkRAFEyEIRFYTG
0 1
BUB1B (human) QQkRAFEyEIRFYTG Y64-p
BUB1B iso2 (human) QQKRAFEYEIRFYTG Y64
BUB1B iso3 (human) QQKRAFEYEIRFYTG Y64
BUB1B (mouse) QQKRAFESEIRFYSG S58
BUB1B (rat) QQKWAFESEIRFYSG S58
S83-p
DVWDRYIsWTEQNYP
0 1
BUB1B (human) DVWDRYIsWTEQNYP S83-p
BUB1B iso2 (human) DVWDRYISWTEQNYP S83
BUB1B iso3 (human) RNINRYISWTEQNYP S97
BUB1B (mouse) DVWDRYINWTEQNYP N77
BUB1B (rat) DVWDRYINWTEQNYP N77
K113-ub
VEALQGEkRYYSDPR
0 3
BUB1B (human) VEALQGEkRYYSDPR K113-ub
BUB1B iso2 (human) gap -
BUB1B iso3 (human) VEALQGEKRYYSDPR K127
BUB1B (mouse) IEALQGETRYYNDPR T107
BUB1B (rat) IEALQGEKRYYSDPR K107
K170-ub
EARENFRkADAIFQE
0 1
BUB1B (human) EARENFRkADAIFQE K170-ub
BUB1B iso2 (human) LQGENFRKADAIFQE K116
BUB1B iso3 (human) EARENFRKADAIFQE K184
BUB1B (mouse) EARENFKKADIIFQE K164
BUB1B (rat) EARENFKKADIVFQQ K164
K182-ub
FQEGIQQkAEPLERL
0 2
BUB1B (human) FQEGIQQkAEPLERL K182-ub
BUB1B iso2 (human) FQEGIQQKAEPLERL K128
BUB1B iso3 (human) FQEGIQQKAEPLERL K196
BUB1B (mouse) FQEGIERKAEPLDRL K176
BUB1B (rat) FQQGIECKAEPLDRL K176
K210-ub
QTLLALEkEEEEEVF
0 2
BUB1B (human) QTLLALEkEEEEEVF K210-ub
BUB1B iso2 (human) QTLLALEKEEEEEVF K156
BUB1B iso3 (human) QTLLALEKEEEEEVF K224
BUB1B (mouse) QAFLALGNEEEEALE N204
BUB1B (rat) QALLALGNEEEEVLG N204
K231-ub
RSTLAELksKGKKtA
0 2
BUB1B (human) RSTLAELksKGKKtA K231-ub
BUB1B iso2 (human) RSTLAELKSKGKKTA K177
BUB1B iso3 (human) RSTLAELKSKGKKTA K245
BUB1B (mouse) RSSLAELKsRGKKMA K224
BUB1B (rat) RSTLAELKSRGKKMA K224
S232-p
STLAELksKGKKtAR
0 3
BUB1B (human) STLAELksKGKKtAR S232-p
BUB1B iso2 (human) STLAELKSKGKKTAR S178
BUB1B iso3 (human) STLAELKSKGKKTAR S246
BUB1B (mouse) SSLAELKsRGKKMAR S225-p
BUB1B (rat) STLAELKSRGKKMAR S225
T237-p
LksKGKKtARAPIIR
0 1
BUB1B (human) LksKGKKtARAPIIR T237-p
BUB1B iso2 (human) LKSKGKKTARAPIIR T183
BUB1B iso3 (human) LKSKGKKTARAPIIR T251
BUB1B (mouse) LKsRGKKMARAPISR M230
BUB1B (rat) LKSRGKKMARAPINR M230
K250-ac
IRVGGALkAPSQNRG
Upstream
Downstream
5 1
Effects on Modified Protein
  • protein stabilization
  • ubiquitination
Effects on Biological Processes:
  • carcinogenesis, inhibited
  • cell cycle regulation
Regulatory protein:
  • BRCA2 (human)
Treatment
  • MG132
  • nocodazole
  • siRNA
BUB1B (human) IRVGGALkAPSQNRG K250-ac
BUB1B iso2 (human) IRVGGALKAPSQNRG K196
BUB1B iso3 (human) IRVGGALKAPSQNRG K264
BUB1B (mouse) SRVGGALkAPGQSRG K243-ac
BUB1B (rat) NRVGGALKAPGQSRG K243
K250-ub
IRVGGALkAPSQNRG
0 4
BUB1B (human) IRVGGALkAPSQNRG K250-ub
BUB1B iso2 (human) IRVGGALKAPSQNRG K196
BUB1B iso3 (human) IRVGGALKAPSQNRG K264
BUB1B (mouse) SRVGGALKAPGQSRG K243
BUB1B (rat) NRVGGALKAPGQSRG K243
K250-sm
IRVGGALkAPSQNRG
Upstream
Downstream
1 0
Effects on Modified Protein
  • protein degradation
Effects on Biological Processes:
  • cell cycle regulation
Treatment
  • caffeine
  • DEVD-CHO
  • medium change
  • MG132
  • nocodazole
  • taxol
  • trichostatin_A
BUB1B (human) IRVGGALkAPSQNRG K250-sm
BUB1B iso2 (human) IRVGGALKAPSQNRG K196
BUB1B iso3 (human) IRVGGALKAPSQNRG K264
BUB1B (mouse) SRVGGALKAPGQSRG K243
BUB1B (rat) NRVGGALKAPGQSRG K243
K304-ub
APPMPRAkENELQAG
0 2
BUB1B (human) APPMPRAkENELQAG K304-ub
BUB1B iso2 (human) APPMPRAKENELQAG K250
BUB1B iso3 (human) APPMPRAKENELQAG K318
BUB1B (mouse) APPVPRAKENELQPG K297
BUB1B (rat) APPVPRAKENELQPG K297
T315-p
LQAGPWNtGRsLEHR
0 3
BUB1B (human) LQAGPWNtGRsLEHR T315-p
BUB1B iso2 (human) LQAGPWNTGRSLEHR T261
BUB1B iso3 (human) LQAGPWNTGRSLEHR T329
BUB1B (mouse) LQPGPWSTDRPAGRR T308
BUB1B (rat) LQPGPWNTDRPLEYR T308
S318-p
GPWNtGRsLEHRPRG
0 1
BUB1B (human) GPWNtGRsLEHRPRG S318-p
BUB1B iso2 (human) GPWNTGRSLEHRPRG S264
BUB1B iso3 (human) GPWNTGRSLEHRPRG S332
BUB1B (mouse) GPWSTDRPAGRRPHD P311
BUB1B (rat) GPWNTDRPLEYRPHS P311
S367-p
PSINHILstRkPGKE
Upstream
0 6
Treatment
  • BI_4834
  • nocodazole
BUB1B (human) PSINHILstRkPGKE S367-p
BUB1B iso2 (human) PSINHILSTRKPGKE S313
BUB1B iso3 (human) PSINHILSTRKPGKE S381
BUB1B (mouse) PSINHVLSTRKPGRE S360
BUB1B (rat) PSINHVLSTRKPGRE S360
T368-p
SINHILstRkPGKEE
0 1
BUB1B (human) SINHILstRkPGKEE T368-p
BUB1B iso2 (human) SINHILSTRKPGKEE T314
BUB1B iso3 (human) SINHILSTRKPGKEE T382
BUB1B (mouse) SINHVLSTRKPGREE T361
BUB1B (rat) SINHVLSTRKPGREE T361
K370-ub
NHILstRkPGKEEGD
0 2
BUB1B (human) NHILstRkPGKEEGD K370-ub
BUB1B iso2 (human) NHILSTRKPGKEEGD K316
BUB1B iso3 (human) NHILSTRKPGKEEGD K384
BUB1B (mouse) NHVLSTRKPGREEGD K363
BUB1B (rat) NHVLSTRKPGREEGD K363
S384-p
DPLQRVQsHQQASEE
0 8
BUB1B (human) DPLQRVQsHQQASEE S384-p
BUB1B iso2 (human) DPLQRVQSHQQASEE S330
BUB1B iso3 (human) DPLQRVQSHQQASEE S398
BUB1B (mouse) DPLQRVQSHQQGCEE S377
BUB1B (rat) DPLQRVQSHQQGCEE S377
Y404-p
MYCKEKIyAGVGEFS
0 18
BUB1B (human) MYCKEKIyAGVGEFS Y404-p
BUB1B iso2 (human) MYCKEKIYAGVGEFS Y350
BUB1B iso3 (human) MYCKEKIYAGVGEFS Y418
BUB1B (mouse) MYCKEKIyAGVGEFS Y397-p
BUB1B (rat) MYCKEKIYAGVGEFS Y397
T434-p
QREAELLtsAEkRAE
0 2
BUB1B (human) QREAELLtsAEkRAE T434-p
BUB1B iso2 (human) QREAELLTSAEKRAE T380
BUB1B iso3 (human) QREAELLTSAEKRAE T448
BUB1B (mouse) RREAELLTSAKKREE T427
BUB1B (rat) RREAELLTSAKKREE T427
S435-p
REAELLtsAEkRAEM
Upstream
2 6
Putative in vivo kinases:
  • TTK (human)
Treatment
  • AZ3146
  • BI2536
  • hesperadin
  • nocodazole
  • seliciclib
  • SP600125
  • staurosporine
  • ZM447439
BUB1B (human) REAELLtsAEkRAEM S435-p
BUB1B iso2 (human) REAELLTSAEKRAEM S381
BUB1B iso3 (human) REAELLTSAEKRAEM S449
BUB1B (mouse) REAELLTSAKKREEM S428
BUB1B (rat) REAELLTSAKKREEM S428
K438-ub
ELLtsAEkRAEMQKQ
0 2
BUB1B (human) ELLtsAEkRAEMQKQ K438-ub
BUB1B iso2 (human) ELLTSAEKRAEMQKQ K384
BUB1B iso3 (human) ELLTSAEKRAEMQKQ K452
BUB1B (mouse) ELLTSAKKREEMQKQ K431
BUB1B (rat) ELLTSAKKREEMQKQ K431
K451-ac
KQIEEMEkKLkEIQT
0 1
BUB1B (human) KQIEEMEkKLkEIQT K451-ac
BUB1B iso2 (human) KQIEEMEKKLKEIQT K397
BUB1B iso3 (human) KQIEEMEKKLKEIQT K465
BUB1B (mouse) KQIEEMERRLKAMQA R444
BUB1B (rat) KQIEEMERKLKAMQT R444
K454-ub
EEMEkKLkEIQTTQQ
0 1
BUB1B (human) EEMEkKLkEIQTTQQ K454-ub
BUB1B iso2 (human) EEMEKKLKEIQTTQQ K400
BUB1B iso3 (human) EEMEKKLKEIQTTQQ K468
BUB1B (mouse) EEMERRLKAMQAVQQ K447
BUB1B (rat) EEMERKLKAMQTIQQ K447
T471-p
TGDQQEEtMPTkETT
0 1
BUB1B (human) TGDQQEEtMPTkETT T471-p
BUB1B iso2 (human) TGDQQEETMPTKETT T417
BUB1B iso3 (human) TGDQQEETMPTKETT T485
BUB1B (mouse) AGGQQEEKMPTEDPA K464
BUB1B (rat) AGDQQEERMLSKDSA R464
K475-ub
QEEtMPTkETTkLQI
0 4
BUB1B (human) QEEtMPTkETTkLQI K475-ub
BUB1B iso2 (human) QEETMPTKETTKLQI K421
BUB1B iso3 (human) QEETMPTKETTKLQI K489
BUB1B (mouse) QEEKMPTEDPARLQI E468
BUB1B (rat) QEERMLSKDSARLEI K468
K479-ub
MPTkETTkLQIASES
0 1
BUB1B (human) MPTkETTkLQIASES K479-ub
BUB1B iso2 (human) MPTKETTKLQIASES K425
BUB1B iso3 (human) MPTKETTKLQIASES K493
BUB1B (mouse) MPTEDPARLQIASGP R472
BUB1B (rat) MLSKDSARLEIASES R472
K488-ub
QIASESQkIPGMTLS
0 1
BUB1B (human) QIASESQkIPGMTLS K488-ub
BUB1B iso2 (human) QIASESQKIPGMTLS K434
BUB1B iso3 (human) QIASESQKIPGMTLS K502
BUB1B (mouse) QIASGPQEMSGVPLS E481
BUB1B (rat) EIASESQEMSGVPPS E481
S509
NCCARETSLAENIWQ
0 1
BUB1B (human) NCCARETSLAENIWQ S509
BUB1B iso2 (human) NCCARETSLAENIWQ S455
BUB1B iso3 (human) NCCARETSLAENIWQ S523
BUB1B (mouse) SSNPREIsPAENILQ S502-p
BUB1B (rat) SSNPREISPAENILQ S502
S521-p
IWQEQPHskGPSVPF
0 1
BUB1B (human) IWQEQPHskGPSVPF S521-p
BUB1B iso2 (human) IWQEQPHSKVSLSLG S467
BUB1B iso3 (human) IWQEQPHSKGPSVPF S535
BUB1B (mouse) ILQEQPDSKGsSMPF S514
BUB1B (rat) ILQEQPETKGPSMPF T514
K522-ub
WQEQPHskGPSVPFS
0 1
BUB1B (human) WQEQPHskGPSVPFS K522-ub
BUB1B iso2 (human) WQEQPHSKVSLSLGP K468
BUB1B iso3 (human) WQEQPHSKGPSVPFS K536
BUB1B (mouse) LQEQPDSKGsSMPFS K515
BUB1B (rat) LQEQPETKGPSMPFS K515
P524
EQPHskGPSVPFSIF
0 1
BUB1B (human) EQPHskGPSVPFSIF P524
BUB1B iso2 (human) KVSLSLGPSVPFSIF P475
BUB1B iso3 (human) EQPHSKGPSVPFSIF P538
BUB1B (mouse) EQPDSKGsSMPFSIF S517-p
BUB1B (rat) EQPETKGPSMPFSIF P517
S537-p
IFDEFLLsEkKNksP
Upstream
0 1
Treatment
  • hesperadin
  • MG132
  • nocodazole
BUB1B (human) IFDEFLLsEkKNksP S537-p
BUB1B iso2 (human) IFDEFLLSEKKNKSP S488
BUB1B iso3 (human) IFDEFLLSEKKNKSP S551
BUB1B (mouse) SIFDESLSDKKDKsP S529
BUB1B (rat) SIFDESLSDKKDKSP S529
K539-ub
DEFLLsEkKNksPPA
0 3
BUB1B (human) DEFLLsEkKNksPPA K539-ub
BUB1B iso2 (human) DEFLLSEKKNKSPPA K490
BUB1B iso3 (human) DEFLLSEKKNKSPPA K553
BUB1B (mouse) FDESLSDKKDKsPAT K531
BUB1B (rat) FDESLSDKKDKSPAT K531
K542-ub
LLsEkKNksPPADPP
0 1
BUB1B (human) LLsEkKNksPPADPP K542-ub
BUB1B iso2 (human) LLSEKKNKSPPADPP K493
BUB1B iso3 (human) LLSEKKNKSPPADPP K556
BUB1B (mouse) SLSDKKDKsPATGGP K534
BUB1B (rat) SLSDKKDKSPATDGP K534
S543-p
LsEkKNksPPADPPR
Upstream
3 25
Kinase, in vitro:
  • CDK1 (human)
Putative in vivo kinases:
  • TTK (human)
Treatment
  • AZ3146
  • BI2536
  • EGF
  • hesperadin
  • MG132_withdrawal
  • nocodazole
  • seliciclib
  • SP600125
  • staurosporine
  • ZM447439
BUB1B (human) LsEkKNksPPADPPR S543-p
BUB1B iso2 (human) LSEKKNKSPPADPPR S494
BUB1B iso3 (human) LSEKKNKSPPADPPR S557
BUB1B (mouse) LSDKKDKsPATGGPQ S535-p
BUB1B (rat) LSDKKDKSPATDGPQ S535
S574-p
ITSNEDVsPDVCDEF
Upstream
2 2
Treatment
  • AZ3146
  • BI2536
  • SP600125
  • ZM447439
BUB1B (human) ITSNEDVsPDVCDEF S574-p
BUB1B iso2 (human) ITSNEDVSPDVCDEF S525
BUB1B iso3 (human) ITSNEDVSPDVCDEF S588
BUB1B (mouse) GTTNEDVSPDICDEL S567
BUB1B (rat) IPANEDISPDVCDEL S567
T600-p
ITGFRNVtICPNPED
0 7
BUB1B (human) ITGFRNVtICPNPED T600-p
BUB1B iso2 (human) ITGFRNVTICPNPED T551
BUB1B iso3 (human) ITGFRNVTICPNPED T614
BUB1B (mouse) ITGFRNVTLCPNPED T593
BUB1B (rat) ITGFRNGILCPNPED I593
T608-p
ICPNPEDtCDFARAA
0 7
BUB1B (human) ICPNPEDtCDFARAA T608-p
BUB1B iso2 (human) gap -
BUB1B iso3 (human) ICPNPEDTCDFARAA T622
BUB1B (mouse) LCPNPEDTCDFARAA T601
BUB1B (rat) LCPNPEDTCDFARAA T601
T620-p
RAARFVStPFHEIMS
Upstream
Downstream
3 0
Effects on Modified Protein
  • molecular association, regulation
  • phosphorylation
  • protein stabilization
Effects on Biological Processes:
  • cell cycle regulation
  • cytoskeletal reorganization
  • signaling pathway regulation
Treatment
  • calyculin_A
  • siRNA
BUB1B (human) RAARFVStPFHEIMS T620-p
BUB1B iso2 (human) gap -
BUB1B iso3 (human) RAARFVSTPFHEIMS T634
BUB1B (mouse) RAARLASTPFHEILS T613
BUB1B (rat) RAARFASTPFHEILP T613
K629-ub
FHEIMSLkDLPsDPE
0 2
BUB1B (human) FHEIMSLkDLPsDPE K629-ub
BUB1B iso2 (human) gap -
BUB1B iso3 (human) FHEIMSLKDLPSDPE K643
BUB1B (mouse) FHEILSSKGIAADPE K622
BUB1B (rat) FHEILPSKSIASDPK K622
S633-p
MSLkDLPsDPERLLP
0 1
BUB1B (human) MSLkDLPsDPERLLP S633-p
BUB1B iso2 (human) gap -
BUB1B iso3 (human) MSLKDLPSDPERLLP S647
BUB1B (mouse) LSSKGIAADPEGLLQ A626
BUB1B (rat) LPSKSIASDPKEGLQ S626
Y660-p
QTACGTIySQTLsIk
0 3
BUB1B (human) QTACGTIySQTLsIk Y660-p
BUB1B iso2 (human) gap -
BUB1B iso3 (human) QTACGTIYSQTLSIK Y674
BUB1B (mouse) AEAHHTVHHQALIIK H649
BUB1B (rat) TEGHHIVHLQTLSVK H649
S665-p
TIySQTLsIkkLsPI
0 1
BUB1B (human) TIySQTLsIkkLsPI S665-p
BUB1B iso2 (human) gap -
BUB1B iso3 (human) TIYSQTLSIKKLSPI S679
BUB1B (mouse) TVHHQALIIKKLsPI I654
BUB1B (rat) IVHLQTLSVKKLSPI S654
K667-ub
ySQTLsIkkLsPIIE
0 1
BUB1B (human) ySQTLsIkkLsPIIE K667-ub
BUB1B iso2 (human) gap -
BUB1B iso3 (human) YSQTLSIKKLSPIIE K681
BUB1B (mouse) HHQALIIKKLsPIIE K656
BUB1B (rat) HLQTLSVKKLSPIIE K656
K668-ub
SQTLsIkkLsPIIED
0 2
BUB1B (human) SQTLsIkkLsPIIED K668-ub
BUB1B iso2 (human) gap -
BUB1B iso3 (human) SQTLSIKKLSPIIED K682
BUB1B (mouse) HQALIIKKLsPIIEE K657
BUB1B (rat) LQTLSVKKLSPIIED K657
S670-p
TLsIkkLsPIIEDsR
Upstream
Downstream
9 34
Effects on Modified Protein
  • intracellular localization
  • molecular association, regulation
  • phosphorylation
Effects on Biological Processes:
  • cell cycle regulation
  • cytoskeletal reorganization
Kinase, in vitro:
  • CDK1 (human)
Putative in vivo kinases:
  • TTK (human)
Regulatory protein:
  • CENPE (human)
Treatment
  • AZ3146
  • BI2536
  • hesperadin
  • MG132_withdrawal
  • MLN8054
  • nocodazole
  • seliciclib
  • SP600125
  • staurosporine
  • taxol
  • thymidine
  • ZM447439
BUB1B (human) TLsIkkLsPIIEDsR S670-p
BUB1B iso2 (human) gap -
BUB1B iso3 (human) TLSIKKLSPIIEDSR S684
BUB1B (mouse) ALIIKKLsPIIEEsR S659-p
BUB1B (rat) TLSVKKLSPIIEDSR S659
S676-p
LsPIIEDsREAtHSs
Upstream
Downstream
9 4
Effects on Modified Protein
  • intracellular localization
  • molecular association, regulation
  • phosphorylation
Effects on Biological Processes:
  • cell cycle regulation
  • cytoskeletal reorganization
Putative in vivo kinases:
  • PLK1 (human)
Regulatory protein:
  • BUB1 (human)
  • CENPE (human)
Treatment
  • AP21967
  • AZ3146
  • BI2536
  • nocodazole
  • okadaic_acid
  • SP600125
  • tanespimycin
  • taxol
  • ZM447439
BUB1B (human) LsPIIEDsREAtHSs S676-p
BUB1B iso2 (human) ICPNPEDSREATHSS S559
BUB1B iso3 (human) LSPIIEDSREATHSS S690
BUB1B (mouse) LsPIIEEsREAtHSS S665-p
BUB1B (rat) LSPIIEDSREATHSS S665
T680-p
IEDsREAtHSsGFSG
Upstream
Downstream
5 0
Effects on Modified Protein
  • intracellular localization
  • molecular association, regulation
  • phosphorylation
Effects on Biological Processes:
  • cell cycle regulation
Kinase, in vitro:
  • PLK1 (human)
Putative in vivo kinases:
  • PLK1 (human)
Treatment
  • BI2536
BUB1B (human) IEDsREAtHSsGFSG T680-p
BUB1B iso2 (human) PEDSREATHSSGFSG T563
BUB1B iso3 (human) IEDSREATHSSGFSG T694
BUB1B (mouse) IEEsREAtHSSGFSR T669-p
BUB1B (rat) IEDSREATHSSGFSR T669
S683-p
sREAtHSsGFSGSSA
0 1
BUB1B (human) sREAtHSsGFSGSSA S683-p
BUB1B iso2 (human) SREATHSSGFSGSSA S566
BUB1B iso3 (human) SREATHSSGFSGSSA S697
BUB1B (mouse) sREAtHSSGFSRSSs S672
BUB1B (rat) SREATHSSGFSRSSS S672
A690
sGFSGSSASVASTSs
0 1
BUB1B (human) sGFSGSSASVASTSs A690
BUB1B iso2 (human) SGFSGSSASVASTSS A573
BUB1B iso3 (human) SGFSGSSASVASTSS A704
BUB1B (mouse) SGFSRSSsSAPsTSS S679-p
BUB1B (rat) SGFSRSSSSVTSTSS S679
S694
GSSASVASTSsIkCL
0 1
BUB1B (human) GSSASVASTSsIkCL S694
BUB1B iso2 (human) GSSASVASTSSIKCL S577
BUB1B iso3 (human) GSSASVASTSSIKCL S708
BUB1B (mouse) RSSsSAPsTSSIKGF S683-p
BUB1B (rat) RSSSSVTSTSSIKGF S683
S697-p
ASVASTSsIkCLQIP
0 1
BUB1B (human) ASVASTSsIkCLQIP S697-p
BUB1B iso2 (human) ASVASTSSIKCLQIP S580
BUB1B iso3 (human) ASVASTSSIKCLQIP S711
BUB1B (mouse) sSAPsTSSIKGFQLL S686
BUB1B (rat) SSVTSTSSIKGFQIL S686
K699-ub
VASTSsIkCLQIPEk
0 1
BUB1B (human) VASTSsIkCLQIPEk K699-ub
BUB1B iso2 (human) VASTSSIKCLQIPEK K582
BUB1B iso3 (human) VASTSSIKCLQIPEK K713
BUB1B (mouse) APsTSSIKGFQLLEK K688
BUB1B (rat) VTSTSSIKGFQILEK K688
K706-ub
kCLQIPEkLELtNET
0 1
BUB1B (human) kCLQIPEkLELtNET K706-ub
BUB1B iso2 (human) KCLQIPEKLELTNET K589
BUB1B iso3 (human) KCLQIPEKLELTNET K720
BUB1B (mouse) KGFQLLEKLELTNDG K695
BUB1B (rat) KGFQILEKLELTTDA K695
T710-p
IPEkLELtNETSENP
0 1
BUB1B (human) IPEkLELtNETSENP T710-p
BUB1B iso2 (human) IPEKLELTNETSENP T593
BUB1B iso3 (human) IPEKLELTNETSENP T724
BUB1B (mouse) LLEKLELTNDGAEDA T699
BUB1B (rat) ILEKLELTTDAAENA T699
S720-p
TSENPTQsPWCSQYR
Upstream
2 4
Treatment
  • AZ3146
  • BI2536
  • SP600125
  • ZM447439
BUB1B (human) TSENPTQsPWCSQYR S720-p
BUB1B iso2 (human) TSENPTQSPWCSQYR S603
BUB1B iso3 (human) TSENPTQSPWCSQYR S734
BUB1B (mouse) GAEDAIQSPWCSQYR S709
BUB1B (rat) AAENAIQSPWCSHYR S709
S733-p
YRRQLLKsLPELSAS
Upstream
0 1
Treatment
  • BI_4834
  • hesperadin
  • MG132
  • nocodazole
BUB1B (human) YRRQLLKsLPELSAS S733-p
BUB1B iso2 (human) YRRQLLKSLPELSAS S616
BUB1B iso3 (human) YRRQLLKSLPELSAS S747
BUB1B (mouse) YRLQLLKSLLELSAF S722
BUB1B (rat) YRLQLLKSLPELSAF S722
K757-ub
MPKLEIEkEIELGNE
0 2
BUB1B (human) MPKLEIEkEIELGNE K757-ub
BUB1B iso2 (human) MPKLEIEKEIELGNE K640
BUB1B iso3 (human) MPKLEIEKEIELGNE K771
BUB1B (mouse) MPVLEIGKEIELGPE K746
BUB1B (rat) MPMLELGKEIELGHE K746
Y766-p
IELGNEDyCIkREYL
0 1
BUB1B (human) IELGNEDyCIkREYL Y766-p
BUB1B iso2 (human) IELGNEDYCIKREYL Y649
BUB1B iso3 (human) IELGNEDYCIKREYL Y780
BUB1B (mouse) IELGPEDYVIKQEHL Y755
BUB1B (rat) IELGHEDYCIKQEHL Y755
K769-ub
GNEDyCIkREYLICE
0 2
BUB1B (human) GNEDyCIkREYLICE K769-ub
BUB1B iso2 (human) GNEDYCIKREYLICE K652
BUB1B iso3 (human) GNEDYCIKREYLICE K783
BUB1B (mouse) GPEDYVIKQEHLTCD K758
BUB1B (rat) GHEDYCIKQEHLTCE K758
T792-p
PRNSAELtVIKVsSQ
Upstream
Downstream
2 0
Effects on Modified Protein
  • enzymatic activity, induced
Effects on Biological Processes:
  • cell cycle regulation
Kinase, in vitro:
  • PLK1 (human)
Putative in vivo kinases:
  • PLK1 (human)
Treatment
  • AZ3146
  • BI2536
  • SP600125
  • ZM447439
BUB1B (human) PRNSAELtVIKVsSQ T792-p
BUB1B iso2 (human) PRNSAELTVIKVSSQ T675
BUB1B iso3 (human) PRNSAELTVIKVSSQ T806
BUB1B (mouse) PRSSAELTMIKASSQ T781
BUB1B (rat) PRNSAELTMIKASSQ T781
S797-p
ELtVIKVsSQPVPWD
0 1
BUB1B (human) ELtVIKVsSQPVPWD S797-p
BUB1B iso2 (human) ELTVIKVSSQPVPWD S680
BUB1B iso3 (human) ELTVIKVSSQPVPWD S811
BUB1B (mouse) ELTMIKASSQPIPWD S786
BUB1B (rat) ELTMIKASSQPLPWD S786
S884-p
EIVHGDLsPRCLILR
Downstream
0 3
Effects on Modified Protein
  • enzymatic activity, inhibited
Effects on Biological Processes:
  • cell cycle regulation
BUB1B (human) EIVHGDLsPRCLILR S884-p
BUB1B iso2 (human) EIVHGDLSPRCLILR S767
BUB1B iso3 (human) EIVHGDLSPRCLILR S898
BUB1B (mouse) EIVHGDLsPRSLILR S873-p
BUB1B (rat) EIVHGDLSPRSLILR S873
K902-ub
HDPYDCNkNNQALKI
0 1
BUB1B (human) HDPYDCNkNNQALKI K902-ub
BUB1B iso2 (human) HDPYDCNKNNQALKI K785
BUB1B iso3 (human) HDPYDCNKNNQALKI K916
BUB1B (mouse) DPYDYVNKDDHAVRI K892
BUB1B (rat) DPYDYINKDDHAVRI K892
R919-m2
FSYSVDLrVQLDVFT
0 1
BUB1B (human) FSYSVDLrVQLDVFT R919-m2
BUB1B iso2 (human) FSYSVDLRVQLDVFT R802
BUB1B iso3 (human) FSYSVDLRVQLDVFT R933
BUB1B (mouse) FSYSVDLRVQLDAFA R909
BUB1B (rat) FSYSVDMRVQLDAFA R909
K988-ub
SQNISELkDGELWNk
0 1
BUB1B (human) SQNISELkDGELWNk K988-ub
BUB1B iso2 (human) SQNISELKDGELWNK K871
BUB1B iso3 (human) SQNISELKDGELWNK K1002
BUB1B (mouse) SQSTSELKDSELWNK K978
BUB1B (rat) SQNTSELKDGELWNK K978
K995-ub
kDGELWNkFFVRILN
Upstream
0 3
Treatment
  • MG132
BUB1B (human) kDGELWNkFFVRILN K995-ub
BUB1B iso2 (human) KDGELWNKFFVRILN K878
BUB1B iso3 (human) KDGELWNKFFVRILN K1009
BUB1B (mouse) KDSELWNKFFVRILN K985
BUB1B (rat) KDGELWNKFFVQILN K985
T1008-p
LNANDEAtVSVLGEL
Upstream
Downstream
2 0
Effects on Modified Protein
  • enzymatic activity, induced
Effects on Biological Processes:
  • cell cycle regulation
Kinase, in vitro:
  • PLK1 (human)
Putative in vivo kinases:
  • PLK1 (human)
Treatment
  • AZ3146
  • BI2536
  • SP600125
  • ZM447439
BUB1B (human) LNANDEAtVSVLGEL T1008-p
BUB1B iso2 (human) LNANDEATVSVLGEL T891
BUB1B iso3 (human) LNANDEATVSVLGEL T1022
BUB1B (mouse) LNASDKSTVSVLGEL T998
BUB1B (rat) LNASDKSTVFILREL T998
K1037-ub
HLNKALWkVGkLtsP
0 1
BUB1B (human) HLNKALWkVGkLtsP K1037-ub
BUB1B iso2 (human) HLNKALWKVGKLTSP K920
BUB1B iso3 (human) HLNKALWKVGKLTSP K1051
BUB1B (mouse) HLNRALWKLGKTIsP K1027
BUB1B (rat) HLNKALWKLGKVISP K1027
K1040-ub
KALWkVGkLtsPGAL
0 3
BUB1B (human) KALWkVGkLtsPGAL K1040-ub
BUB1B iso2 (human) KALWKVGKLTSPGAL K923
BUB1B iso3 (human) KALWKVGKLTSPGAL K1054
BUB1B (mouse) RALWKLGKTIsPEAL K1030
BUB1B (rat) KALWKLGKVISPEAS K1030
T1042-p
LWkVGkLtsPGALLF
Upstream
1 2
Treatment
  • AZ3146
  • BI2536
  • SP600125
  • ZM447439
BUB1B (human) LWkVGkLtsPGALLF T1042-p
BUB1B iso2 (human) LWKVGKLTSPGALLF T925
BUB1B iso3 (human) LWKVGKLTSPGALLF T1056
BUB1B (mouse) LWKLGKTIsPEALLT I1032
BUB1B (rat) LWKLGKVISPEASLI I1032
S1043-p
WkVGkLtsPGALLFQ
Upstream
Downstream
3 11
Effects on Biological Processes:
  • cell cycle regulation
Kinase, in vitro:
  • CDK1 (human)
Putative in vivo kinases:
  • TTK (human)
Treatment
  • AZ3146
  • BI2536
  • hesperadin
  • nocodazole
  • seliciclib
  • SP600125
  • staurosporine
  • ZM447439
BUB1B (human) WkVGkLtsPGALLFQ S1043-p
BUB1B iso2 (human) WKVGKLTSPGALLFQ S926
BUB1B iso3 (human) WKVGKLTSPGALLFQ S1057
BUB1B (mouse) WKLGKTIsPEALLTQ S1033-p
BUB1B (rat) WKLGKVISPEASLIQ